Trial Profile
Multicenter and prospective study to determine the satisfaction with actonel (risedronate sodium) [risedronic acid] 35mg once a week using biochemical markers of bone as a control, in postmenopausal women with osteoporosis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Mar 2008
Price :
$35
*
At a glance
- Drugs Risedronic acid (Primary)
- Indications Postmenopausal osteoporosis
- Focus Therapeutic Use
- Acronyms ROSPA-CTx
- Sponsors Sanofi
- 28 Mar 2008 New trial record.